Wu, T.; Pu, C.; Wu, X.; Wang, Q.; Zhang, K.
Chemo-Free Treatment Using Anti-PD-1 Antibodies with Lenvatinib in Unresectable Gallbladder Cancer: PD-L1 May Be a Potential Biomarker for a Better Outcome. Diagnostics 2023, 13, 1833.
https://doi.org/10.3390/diagnostics13111833
AMA Style
Wu T, Pu C, Wu X, Wang Q, Zhang K.
Chemo-Free Treatment Using Anti-PD-1 Antibodies with Lenvatinib in Unresectable Gallbladder Cancer: PD-L1 May Be a Potential Biomarker for a Better Outcome. Diagnostics. 2023; 13(11):1833.
https://doi.org/10.3390/diagnostics13111833
Chicago/Turabian Style
Wu, Tiantian, Changsheng Pu, Xianjia Wu, Qiang Wang, and Keming Zhang.
2023. "Chemo-Free Treatment Using Anti-PD-1 Antibodies with Lenvatinib in Unresectable Gallbladder Cancer: PD-L1 May Be a Potential Biomarker for a Better Outcome" Diagnostics 13, no. 11: 1833.
https://doi.org/10.3390/diagnostics13111833
APA Style
Wu, T., Pu, C., Wu, X., Wang, Q., & Zhang, K.
(2023). Chemo-Free Treatment Using Anti-PD-1 Antibodies with Lenvatinib in Unresectable Gallbladder Cancer: PD-L1 May Be a Potential Biomarker for a Better Outcome. Diagnostics, 13(11), 1833.
https://doi.org/10.3390/diagnostics13111833